Ignite Creation Date:
2025-12-24 @ 11:16 PM
Ignite Modification Date:
2026-06-25 @ 1:07 AM
Study NCT ID:
NCT03927456
Status:
UNKNOWN
Last Update Posted:
2021-06-03
First Post:
2019-04-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of SHR6390 in Combination With Fulvestrant in Patients With HR Positive and HER2 Negative Advanced Breast Cancer
Sponsor:
Jiangsu HengRui Medicine Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-06-13
Start Date Type:
ACTUAL
Primary Completion Date:
2021-12-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-12-30
Completion Date Type:
ESTIMATED
First Submit Date:
2019-04-17
First Submit QC Date:
None
Study First Post Date:
2019-04-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-05-31
Last Update Post Date:
2021-06-03
Last Update Post Date Type:
ACTUAL